Oxford Pharmaceuticals, a British-based company, started construction on a $29.4 million, 120,000 square foot, generic drug manufacturing plant. The facility will be located on 23.4 acres at the Jefferson Metropolitan Park-Lakeshore in Birmingham, Alabama.
The plant will produce, package and research generic drugs. The project will initially create 61 jobs, but that figure is projected to grow to 200 within 10 years.
John Schultz, President/General Manager of Oxford Pharmaceuticals in Birmingham, said Alabama’s largest city offers resources like Innovation Depot and the University of Alabama that gave Birmingham a competitive advantage over other cities when it came to selecting a site. Innovation Depot is providing the company with temporary space while its production facility is being built.
“We were looking at Nashville, we were looking at Huntsville. We spent some time investigating Charlotte,” Schultz said. “With the help of Innovation Depot and the training support that we will get from the state in AIDT and the partnership with UAB, they are all great incentives to come to Birmingham that some of the other places didn’t have.”
“It’s a well-educated, diverse workforce here in Birmingham and we’re looking forward to tapping into it,” he said.
“We’re fortunate to have a diversified economy, a diversified set of large and small employers that do many, many different things and require many different skill sets,” Brian Hilson, CEO of the Birmingham Business Alliance.
“If you look at economic growth in Birmingham, Alabama, and you look at the best opportunities that we have to grow, one of the things that comes to mind is a company just like this: a pharmaceutical manufacturer that has selected the city of Birmingham, Jefferson County, state of Alabama for a manufacturing plant,” he said. “I like to think we can do more of these in the future.”